Trivaris triamcinolone acetonide injectable suspension regulatory update

FDA approved an NDA from Allergan for 80 mg/mL of Trivaris triamcinolone acetonide for use as an intravitreal, intramuscular or intra-articular injection to treat sympathetic ophthalmia, temporal arte...